CURRENT SPONSORS


Diagnostics

Lunar Achilles | GE Healthcare Lunar

GE Healthcare Lunar

Have Company Representative Contact Me
Send More Information
Send Pricing
Would like a Demo
Would like to Order
GE Healthcare Lunar Lunar Achilles Logo
GE Healthcare Lunar Lunar Achilles Logo
The Achilles ultrasonometer is a compact, portable, cost-effective solution for evaluating risk of osteoporotic fracture. As a osteoporosis assesment tool, it can be used to drive referrals to your table system. Its low precision error makes it suitable to monitor bone changes over time such as those associated with disease progression or response to therapy. Currently, there are more than 5,000 facilities around the world who have tested millions of patients with the Achilles bone ultrasonometer.

 

The Achilles Express is a proven bone ultrasonometer that brings fracture risk assessment to the forefront of healthcare. Numerous clinical studies show that ultrasonometry of the heel using Achilles is an economical and reliable complement to DXA.[1,2,3,4,5] Testing is fast and you get immediate results enabling you to counsel patients and make sound treatment decisions.

Achilles Express fits in less than two square feet of office space. Easy to take on the road, to satellite offices, nursing homes, or outreach programs. Achilles' portability makes it ideal to use as an early assessment tool for identifying patients for DXA scans. The complete system weighs just 24 lbs (11kg) and the ergonomic design makes it easy to carry. Just slip it into the front east or trunk of your care and you are ready to travel.

Backed by Solid Science

The Achilles ultrasonometer has been proven in prospective studies to predict fracture risk in postmenopausal women, ages 45 to 75+ years. These studies show Achilles to be as effective as DXA of the femur in predicting hip fracture risk.[1,5,6] Three large population-based studies proved that QUS of the calcaneus worked as well as central DXA for identification of women at high risk for prevalent osteoporotic vertebral fractures.[2,3,4] In a direct comparison to other QUS devices the Achilles Stiffness Index was the most sensitive to vertebral fracture status.[2]

Monitor Treatment

Achilles has been proven to have precision suitable for monitoring bone changes through aging or in response to therapy.[7]

SmartDry Technology

With SmartDry technology you will not sacrifice precision or convenience. SmartDry keeps the foot dry by using water encapsulated in membranes that conform closely to the patient's foot and are temperature controlled, reducing variation. SmartDry's 'closed-water system' requires virtually no maintenance and measurement and clean-up are easy since isopropyl alcohol or ethanol are used as coupling agents.

Easy to Use and Interpret

The one-minute ultrasound test is simple to perform: a touch of the built-in LCD screen is all it takes. Achilles Express automatically calculates the patient’s Stiffness Index which is compared to young adult and age-matched references to provide both a T-score and Z-score. These, together with other risk factors, assist physicians in the diagnosis of osteoporosis.

T-Scores

Achilles Express provides T-scores comparable to spine or femur BMD. The World Health Organization (WHO) defines fracture risk based on the 'T-score' for bone mineral density (BMD) measured by DEXA. The T-score is the difference between the patient value and the average value in healthy young adults divided by standard deviation.

Portable

The Achilles Express offers superior portability. This lightweight (22 pounds), rugged ultrasonometer is easily transported or carried between offices using its built-in handle.

Compact and Efficient

The Achilles Express is perfect for the busy physicians’ office. It includes an internal microcomputer with memory for 100 patient results, and a built-in printer. The compact design occupies less than 2 square feet of office space allowing it to be stored under a desk or in a closet when idle.

Osteoporosis Facts

·       Approximately 40% of 50-year-old women and 25% of 50-year-old men will experience at least one osteoporotic fracture during their remaining lifetime. [8,9]

·       A woman’s risk of an osteoporotic fracture is much higher than that of breast cancer, stroke and heart attack combined.[10,11,12,13]

References:

1. Marc-Antoine Krieg et al Prediction of Hip Fracture Risk by Quantitative Ultrasound in More Than 7000 Swiss Woment >=70 years of Age: Comparison of Three Technologically Different Bone Ultrasound Devices in the SEMOF Study. JBMR Volume 21, Number 9, 2006

2. Claus C GlŸer et al Association of Five Quantitative Ultrasound Devices and Bone Densitometry With Osteoporotic Vertebral Fractures in a Population-based Sample: The OPUS study. JBMR Volume 19, Number 5, 2004

3. B. Frediani et al Calcaneus Ultrasonometry and Dual-Energy XRay Absorptiometry for the Evaluation of Vertebral Fracture Risk. Calcif Tissue Int (2006) 79:223-229

4. F. Hartl et al Discriminatory Ability of Quantitative Ultrasound Parameters and Bone Mineral Density in a Population-Based Sample of Postmenopausal Women With Vertebral Fractures: Results of the Basel Osteoporosis Study

5. D. Hans et al Ultrasonographic Heel Measurements to Predict Hip Fracture in Elderly Women: The EPIDOS Prospective Study. The Lancet, Vol 348:511-514, 1996

6. Paul W. Thompson et al Quantitative Ultrasound (QUS) of the Heel Predicts Wrist and Osteoporosis-Related Fractures in Women Age 45-75 Years. Journal of Clinical Densitometry, Vol 1, No. 3, 219-225, Fall 1998.

7. S. Gonnelli et al Heel Ultrasonography in Monitoring Alendronate Therapy: A Four-Year Longitudinal Study. Osteoporosis Int (2002) 13:415-421

8. Melton LJ III, Lane AW, Cooper C, Eastell R, O’Fallon WM, Riggs BL, 1993 Prevalence and incidence of vertebral fractures. Osteoporosis Int 3:113-119.

9. Randell A, Sambrook PN, Nguyen TV, et al. (1995) Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporosis Int 5:427-432

10. Annual incidence women all ages. National Osteoporosis Foundation, Physician’s

Guide to Prevention and Treatment of Osteoporosis, Washington, DC; National Osteoporosis Foundation, 2003.

11. Annual estimate women 29+. American Heart Association, Heart & Stroke Facts, Dallas, TX; American Heart Association, 2003.

12. Annual estimate women 30+. American Heart Association, Heart & Stroke Facts, Dallas, TX; American Heart Association, 2003.

13. 2005 new cases women of all ages. American Cancer Society, Cancer Facts & Figures 2005, Atlanta, GA; American Cancer Society, 2005.

 

 





Product Testimonials

for Lunar Achilles








Physicians  Pharmaceuticals  Diagnostics  Health News  Editorials  Manufacturers  Patients  Other Resources  Health Links  Industry Links  Advertise  Contact Us
Copyright © 2009-2011 Physicians Office Resource
10888